cancer of unknown primary Oct 13, 2020 Twist Bioscience, Neogene Therapeutics Partner to Develop Personalized CAR T Cells, TCR Therapies Oct 1, 2020 TargetCancer Foundation Enrolls First Patient to Decentralized, Rare Cancer TRACK Study Sep 3, 2020 Oncocyte, Guardian Research Network Partner to Improve Precision Medicine Clinical Trials Aug 11, 2020 Research Advocates, Leading Docs to Expand Precision Medicine Access With Decentralized Model Premium Jun 2, 2020 Evidence for Targeted Treatment Builds in Cancers of Unknown Primary but Randomized Data Pending Premium Apr 28, 2020 New Iteration of AACR's Project GENIE Focuses on Real-World Outcomes to Enhance Precision Oncology Premium Feb 20, 2020 High Expression of Alternative Checkpoints, CD68 Associated With Resistance to Anti-PD1 Therapy Feb 19, 2020 Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing Jan 27, 2020 Johns Hopkins University Opens New Cancer Center With $5M in Mark Foundation Funding Nov 6, 2019 Merck, Promega Collaborate to Develop MSI CDx for Keytruda Oct 29, 2019 Oncolytic Viruses May Help Cancer Patients Overcome Resistance to Immunotherapy, Research Shows Premium Oct 28, 2019 Genomic Test Makers Pilot New Approaches to Overcome Roadblocks in CUP Patient Treatment Premium Sep 30, 2019 Carcinoma of Unknown Primary Investigators Pursue Molecular Targets to Tailor Treatments Premium Sep 10, 2019 Repare Therapeutics Using CRISPR to Develop Cancer Treatments for Synthetic Lethal Targets Premium Aug 7, 2019 Pediatric Cancer Researchers, Clinicians Look to Enhance Molecular Data Collection, Distribution Jun 25, 2019 Pediatric Cancer Big Data Initiatives Could Help Set Best Practices for Sequencing, Data Sharing Premium Jun 18, 2019 Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms Premium May 16, 2019 NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy Premium Apr 15, 2019 Maternal Cancer Detection From Noninvasive Prenatal Screening Results Improved by Algorithm Apr 10, 2019 Genome-Scale CRISPR Screening Helps Identify New Cancer Drug Targets Load More Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma
